James E. Flynn 13D/13G Filings for TherapeuticsMD, Inc. (TXMD)

James E. Flynn 13D and 13G filings for TherapeuticsMD, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-07-07
2:02 pm
Purchase
2021-07-0213GTherapeuticsMD, Inc.
TXMD
James E. Flynn413,256
4.900%
413,256increase
(New Position)
Filing